Will_Wong

LGND-A-B-C correction to wave {iv} nearing completion

看多
NASDAQ:LGND   Ligand Pharmaceuticals Incorporated
1
Entry point coming soon. With a recent earning report that surpassed estimates, LGND is expected to reach triple digit soon. A few analysts have upgraded LGND to a BUY with targets in the triple digits.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。